VistaGen appoints healthcare attorney Mary L. Rotunno to board

Vistagen Therapeutics, Inc.

Mary L. Rotunno, J.D., appointed to VistaGen's Board of Directors effective July 6, 2021.
Rotunno currently serves as General Counsel of El Camino Health, a $1B revenue health system.
She is considered an independent director under Nasdaq listing rules.
Company entered into a standard indemnification agreement with Rotunno.
Rotunno brings over 30 years of healthcare legal and nursing experience.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Mary L. Rotunno

Director

VTGN · Vistagen Therapeutics, Inc.

Effective: 2021-07-06
Filed: July 8, 2021, 7:59 PM ET

On July 6, 2021, Mary L. Rotunno J.D. was appointed to serve on the Board of Directors

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Mary L. Rotunno was appointed as Director at Vistagen Therapeutics, Inc..

Action: appointed
Role: Director

Exact text from the filing

On July 6, 2021, Mary L. Rotunno J.D. was appointed to serve on the Board of Directors

View on SEC.gov

Vistagen Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-21-007757

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.